| |
| |
|
| Insider
Information: |
Kellerman Donald J |
| Relationship: |
VP, Clinical Dev & Med... |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
56,331 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,771 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,331 |
|
|
| Total
Value |
$6,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -185.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
SVP,Clinical Dev & Med... |
2013-03-01 |
0 |
2011-08-04 |
0 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
VP, Clinical Dev & Med... |
2022-03-31 |
56,331 |
2016-08-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZSAN |
Zosano Pharma Corp |
VP, Clinical Dev & Med Affairs |
• – – |
2022-03-31 |
4 |
S |
$0.21 |
$842 |
D/D |
(4,006) |
56,331 |
0 |
% |
|
| ZSAN |
Zosano Pharma Corp |
VP, Clinical Dev & Med Affairs |
• – – |
2021-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,337 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
VP, Clinical Dev & Med Affairs |
• – – |
2021-06-04 |
4 |
S |
$0.81 |
$1,376 |
D/D |
(1,709) |
50,337 |
0 |
% |
|
| ZSAN |
Zosano Pharma Corp |
VP, Clinical Dev & Med Affairs |
• – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
52,046 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
VP, Clinical Dev & Med Affairs |
• – – |
2016-08-19 |
4 |
B |
$1.32 |
$21,014 |
D/D |
15,920 |
15,920 |
2.74 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-03-01 |
4 |
D |
$25.00 |
$94,875 |
D/D |
(3,795) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-02-01 |
4 |
AS |
$24.73 |
$35,339 |
D/D |
(1,429) |
3,479 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-01-26 |
4 |
D |
$24.75 |
$21,557 |
D/D |
(871) |
4,908 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
5,779 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
4,736 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2013-01-25 |
4 |
D |
$24.75 |
$29,873 |
D/D |
(1,207) |
3,529 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2012-11-20 |
5 |
A |
$9.89 |
$5,511 |
D/D |
557 |
1,986 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2012-01-26 |
4 |
D |
$13.84 |
$13,051 |
D/D |
(943) |
1,429 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2012-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
2,372 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2011-12-02 |
4 |
D |
$13.62 |
$40,864 |
D/D |
(3,000) |
122 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2011-08-24 |
4 |
D |
$12.34 |
$49,370 |
D/D |
(4,000) |
3,122 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2011-08-04 |
4 |
D |
$13.43 |
$55,439 |
D/D |
(4,128) |
7,122 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP,Clinical Dev & Med Affairs |
• – – |
2011-08-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
11,250 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
